0001950047-24-002721.txt : 20240327 0001950047-24-002721.hdr.sgml : 20240327 20240327162216 ACCESSION NUMBER: 0001950047-24-002721 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240327 DATE AS OF CHANGE: 20240327 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 24790987 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: AFEYAN NOUBAR CENTRAL INDEX KEY: 0001222012 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O FLAGSHIP PIONEERING, INC. STREET 2: 55 CAMBRIDGE PARKWAY, SUITE 800E CITY: CAMBRIDGE STATE: MA ZIP: 02142 144 1 primary_doc.xml 144 0001222012 XXXXXXXX LIVE 0001682852 MODERNA INC 001-38753 200 Technology Square Cambridge MA 02139 6177146500 NOUBAR B AFEYAN Director COMMON Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

15000 1611150.00 382073208 03/27/2024 NASDAQ Common 05/01/2012 Private Placement Issuer N 15000 05/01/2012 Cash N 10b5-1 Sales Plan for NOUBAR B AFEYAN

200 Technology Square Cambridge MA 02139

Common 03/20/2024 15000 1535820.00 10b5-1 Sales Plan for NOUBAR B AFEYAN

200 Technology Square Cambridge MA 02139

Common 03/13/2024 15000 1628031.00 03/27/2024 11/07/2023 /s/ Noubar B. Afeyan